New Advances in Lung Cancer Chemotherapy: Topotecan and the Role of Topoisomerase I Inhibitors

Publisher： Karger

E-ISSN： 1423-0232|61|1|14-24

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.1, 2001-09, pp. : 14-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future Role of Topotecan in the Treatment of Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 55-59

Karger

Access to resources Recommend Favorite

Clinical Outcome of Topotecan: New Strategies Play an Important Role in the Treatment of Lung Cancer, Other Solid Tumors, and Hemoblastosis

By  

Oncology Research and Treatment, Vol. 21, Iss. 4, 1999-01 ,pp. : 1-1

Karger

Access to resources Recommend Favorite

New Drugs in Colorectal Cancer: A Review of Antitumor Activity and Cross-Resistance Patterns of Topoisomerase I Inhibitors, Thymidylate Synthetase Inhibitors, and Oxaliplatin

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-05 ,pp. : 95-103

Karger

Access to resources Recommend Favorite

Topotecan – A Novel Topoisomerase I Inhibitor: Pharmacology and Clinical Experience

By  

Oncology, Vol. 56, Iss. 1, 1999-01 ,pp. : 1-12

Karger

Access to resources Recommend Favorite

A Phase I Trial of a 5-Day Schedule of Intravenous Topotecan and Etoposide in Previously Untreated Patients with Small-Cell Lung Cancer

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 25-29

Karger

Access to resources Recommend Favorite